Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer

Article

Abstract: Purpose: We show the result of a randomized phase II clinical trial with an epidermal growth factor

Palabras claves:

Autores:

Abreu D.A., Bravo I., Brooks S.A., Carmen Elena Viada, Carrillo C.d.C., Dávila A.L., De La Torre A.V., Del Pino M.M., Dueñas M.G., Ferrer M.C., Marinello G.G., Ramos T.C., Rives R., Rodríguez M.O., Verdecia B.G., Vinageras E.N.

Fuentes:

scopus